Drawing for IMMUNOTAC

USPTO serial 88108651

IMMUNOTAC

Reviewed by CopyMark Law Group

Reg. 6707689Status 700Registered
Filing date
Status date
Registration date
Apr 19, 2022
Examiner
STIGLITZ, SUSAN R
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IMMUNOTAC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joi A. White

Joi A. White CARR & FERRELL LLP120 CONSTITUTION DRIVEMENLO PARK, CA 94025UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Pharmaceutical and therapeutics research and development services for systemically delivered, locally active immune modulatory conjugates; research and development of systemically delivered, locally active immune modulatory conjugates in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune modulatory conjugates in the field of human therapeutics; research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases with systemically delivered, locally active immune modulatory conjugates; pharmaceutical product development of systemically delivered, locally active immune modulatory conjugatesACTIVEAug 11, 2021

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (R.PR): Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.

DateCodeEventWhat it means
Apr 19, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 17, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 16, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 18, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 17, 2022SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 17, 2022EX4GSOU EXTENSION 4 GRANTED—
Feb 17, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 10, 2022IUAFUSE AMENDMENT FILED—
Feb 10, 2022EXT4SOU EXTENSION 4 FILED—
Feb 10, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 10, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 13, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 11, 2021EX3GSOU EXTENSION 3 GRANTED—
Aug 11, 2021EXT3SOU EXTENSION 3 FILED—
Aug 11, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 12, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 10, 2021EX2GSOU EXTENSION 2 GRANTED—
Feb 10, 2021EXT2SOU EXTENSION 2 FILED—
Feb 10, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 5, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 3, 2020EX1GSOU EXTENSION 1 GRANTED—
Aug 3, 2020EXT1SOU EXTENSION 1 FILED—
Aug 3, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 11, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 29, 2019ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Sep 18, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Aug 20, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 20, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 31, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 15, 2019ALIEASSIGNED TO LIE—
Jul 8, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 19, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 18, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 18, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 31, 2018LOPRLETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN—
Dec 28, 2018LOPTLETTER OF PROTEST EVIDENCE FORWARDED—
Dec 19, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 19, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 19, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2018DOCKASSIGNED TO EXAMINER—
Sep 15, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 11, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance